Expert Interview
A Second Opinion: Discussing Exact Sciences’ new COLOGUARD PLUS test for Colorectal Cancer Screening
Ticker(s): EXAS, GHInstitution: Harvard & Beth Israel Deaconess Medical Center
- Assistant Professor of Medicine at Harvard Medical School, Gastroenterologist at BIDMC & Director of Community Endoscopy for BIDMC.
- Manages over 100 patients with gastroparesis.
- Special areas of interest include: enteral and parenteral nutrition, intestinal failure, and gastrointestinal dysmotility;has developed national and international reputation based on his expertise in nutrition support, intestinal failure, gastric dysmotility and bariatric surgery complications.
How much of an uptick have you seen in screenings completed because of Cologuard?
Are patients generally up to date with recommended colorectal cancer screenings?
Added By: ben_adminIs the Cologuard Plus a big improvement compared to the first generation test?
Will your prescribing of Cologuard tests increase now that the Plus test is available?
Added By: ben_adminHow will the Cologuard Plus test compete with blood based assays, such as the SHIELD test?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
